Welcome to our dedicated page for Blend Labs SEC filings (Ticker: BLND), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Decoding Blend Labs’ cloud-software story across mortgages, consumer loans, and title services can mean navigating hundreds of pages of technical disclosures. If you have ever searched “Blend Labs SEC filings explained simply” or wondered how rising interest rates flow through Blend’s revenue model, this page is built for you. Stock Titan’s AI instantly surfaces the metrics that matter—so you are not lost in accounting jargon when a new 10-K drops.
Our platform delivers every filing type the moment EDGAR publishes it. Open the Blend Labs annual report 10-K simplified to see subscription vs. usage revenue outlined in plain language, or jump into a Blend Labs quarterly earnings report 10-Q filing for trend-line charts on cash burn and customer concentration. Real-time alerts flag Blend Labs Form 4 insider transactions—yes, “Blend Labs insider trading Form 4 transactions” appear here within seconds—while concise briefs turn each Blend Labs 8-K material events explained page into a two-minute read. Need governance details? The Blend Labs proxy statement executive compensation section highlights equity grants and performance goals without the legalese.
Whether you are tracking Blend Labs executive stock transactions Form 4, benchmarking margins with our “Blend Labs earnings report filing analysis,” or simply understanding Blend Labs SEC documents with AI, Stock Titan saves hours. AI-powered summaries, side-by-side historical comparisons, and downloadable tables let analysts monitor how mortgage-volume swings affect the Blend Platform and Title segments, spot material contract updates, and see dilution impacts before markets react. No more searching multiple sources—every disclosure, every insight, one tab.
Blend Labs (BLND) disclosed an insider transaction by its Head of Legal and People. On 10/20/2025, the reporting person sold 4,000 Class A shares at $3.50 per share under a Rule 10b5-1 trading plan adopted on March 14, 2025. Following the sale, the insider beneficially owned 380,631 shares, held directly.
Blend Labs (BLND) reported an insider transaction by its Head of Revenue. On 10/15/2025, the reporting person sold 25,000 shares of Class A common stock at a $3.3403 weighted average price, with individual trades ranging from $3.33 to $3.385. The sales were made under a Rule 10b5-1 trading plan adopted on March 14, 2025. Following the transaction, the insider beneficially owns 687,909 shares, held directly.
Blend Labs (BLND) received a Form 144 notice indicating an intended sale of 25,000 shares of common stock through Charles Schwab & Co., Inc. with an aggregate market value of $83,509, targeting an approximate sale date of October 15, 2025 on the NYSE. The form lists 255,696,747 shares outstanding.
The seller acquired these 25,000 shares on February 17, 2020 via “Exercise and Hold,” paid in cash. Recent activity disclosed three prior sales of 25,000 shares each on July 15, 2025 ($90,829), August 15, 2025 ($71,873), and September 15, 2025 ($109,069), by Brian Kneafsey.
Reporting person: Winnie Ling, Head of Legal and People and officer of Blend Labs, Inc. (BLND), reported a sale of common stock executed under a Rule 10b5-1 trading plan adopted on
The Form 4 shows a disposition of 4,000 shares of Class A common stock on
Blend Labs, Inc. (BLND) filed a Form 144 reporting a proposed sale of 4,000 common shares through Charles Schwab & Co., Inc. with an approximate sale date of 10/02/2025 on the NYSE. The shares were acquired on 02/20/2025 as the lapse of restricted stock under the company’s equity compensation plan and were paid by equity compensation.
The filing also lists multiple recent open-market sales by (and an address for) Winnie Ling across July–September 2025, each showing trade dates, share amounts, and gross proceeds. The Form 144 includes the seller’s representation that they are not aware of undisclosed material adverse information about the issuer.
Winnie Ling, Head of Legal and People at Blend Labs, Inc. (BLND), reported a sale of 6,500 shares of Class A common stock on 09/18/2025. The shares were sold under a pre-established Rule 10b5-1 trading plan adopted on March 14, 2025, at a weighted average price of $4.2951 per share (sales ranged from $4.265 to $4.30). After the transaction, the reporting person beneficially owned 388,631 shares, held directly. The Form 4 was signed on 09/19/2025 and includes an offer to provide detailed per-price sale quantities to the Commission staff on request.
Form 144 notice for Blend Labs, Inc. (BLND)
This filing discloses a proposed sale of 6,500 common shares to be executed on 09/18/2025 through Charles Schwab & Co., with an aggregate market value listed as $27,918.00. The shares were acquired by the seller on 05/20/2024 via a restricted stock lapse as equity compensation from Blend Labs, Inc. The filing also reports prior sales by the same person, Winnie Ling, totaling 45,500 shares sold across seven transactions between 07/03/2025 and 09/05/2025, with aggregate gross proceeds of $169,091.00. The filer certifies no undisclosed material adverse information and follows Rule 144 disclosure requirements.
Blend Labs insider sale under 10b5-1 plan — Brian Kneafsey, Head of Revenue and an officer of Blend Labs (BLND), reported a sale of 25,000 shares of Class A common stock on 09/15/2025. The sale was executed under a Rule 10b5-1 trading plan adopted March 14, 2025, and the weighted average sale price for the block was $4.3628 per share, with individual trade prices ranging from $4.32 to $4.40. After the transaction, Kneafsey beneficially owned 712,909 shares, held directly. The Form 4 was signed by an attorney-in-fact on 09/16/2025.
Form 144 filed for Blend Labs, Inc. (BLND) reporting a proposed sale of 25,000 common shares through Charles Schwab & Co., Inc. with an approximate aggregate market value of $109,069 and an approximate sale date of 09/15/2025 on the NYSE. The filer shows these 25,000 shares were acquired on 02/17/2020 by exercise and held, with payment in cash. The filing lists prior dispositions by Brian Kneafsey totaling 175,000 shares sold between 06/16/2025 and 08/15/2025 for aggregate gross proceeds of $575,145. The form includes the standard representation that the seller is not aware of undisclosed material adverse information.
FAQ
What is the current stock price of Blend Labs (BLND)?
What is the market cap of Blend Labs (BLND)?
